Related Experiment Video
Updated: Mar 29, 2026

Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
Published on: February 21, 2025
Pre-analytic variability in cardiovascular biomarker testing
Roberto Cemin1, Massimo Daves1
11 Department of Cardiology, San Maurizio Regional Hospital of Bolzano, Bolzano, Italy ; 2 Clinical Pathology Laboratory, Hospital of Merano, Merano, Italy.
Insights
Pre-analytic variability significantly impacts cardiovascular biomarker testing quality. Understanding factors affecting cardiac troponins and natriuretic peptides is crucial for accurate clinical cardiology results and avoiding errors.
Area of Science:
- Laboratory Medicine
- Clinical Cardiology
- Biomarker Analysis
Background:
- Laboratory medicine plays an increasingly vital role in clinical cardiology.
- Numerous cardiovascular biomarkers have been introduced, enhancing diagnostic capabilities.
- Pre-analytic variability is a major, often underestimated, source of laboratory errors.
Purpose of the Study:
- To review the determinants of pre-analytic variability in cardiovascular biomarker testing.
- To highlight the significance of pre-analytic factors for common biomarkers.
- To improve the quality of laboratory results in cardiology.
Main Methods:
- Literature review focusing on pre-analytic variability.
- Analysis of factors affecting cardiovascular biomarker testing.
- Emphasis on cardiac troponins and natriuretic peptides.
Main Results:
- Pre-analytic variability is a substantial source of bias in laboratory testing.
- Specific determinants of variability for cardiac troponins and natriuretic peptides are identified.
- Awareness of these factors is essential for physicians.
Conclusions:
- Addressing pre-analytic variability is critical for reliable cardiovascular biomarker results.
- Understanding pre-analytic factors enhances the accuracy of clinical cardiology.
- Minimizing laboratory errors requires attention to pre-analytic sample handling.
Abstract:
The impact of laboratory medicine on clinical cardiology has dramatically increased over the years and a lot of cardiovascular biomarkers have been recently proposed. In order to avoid clinical mistakes, physicians should be well aware of all the aspects, which could affect the quality of laboratory results, remembering that pre-analytic variability is an often overlooked significant source of bias, determining the vast majority of laboratory errors. This review addresses the determinants of pre-analitycal variability in cardiovascular biomarker testing, focusing on the most widespread biomarkers, which are cardiac troponins and natriuretic peptides.
Related Concept Videos
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Errors occurring during blood pressure monitoring
Several factors...
Systematic Error: Methodological and Sampling Errors
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
Dosage Regimen: Individualization

